[Effect of sulfocamphocaine on the systemic and cerebral hemodynamics of patients with chronic cerebral circulatory failure].
D000328:Adult; D000368:Aged; D002164:Camphor / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000503:physiopathology; D002908:Chronic Disease; D004338:Drug Combinations / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011343:Procaine / Q000627:therapeutic use*; D013997:Time Factors
D004338:Drug Combinations; D011343:Procaine; C012050:sulfocamphocaine; D002164:Camphor
Vliianie sul'fokamfokaina na sistemnuiu i tserebral'nuiu gemodinamiku u bol'nykh khronicheskoĭ nedostatochnost'iu mozgovogo krovoobrashcheniia.